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The death of poliovirus-infected cells may occur in two forms: canonical cytopathic effect (CPE) (on productive infections) or
apoptosis (when the viral reproduction is hindered by certain drugs or some other restrictive conditions). Morphological
manifestations of the CPE and apoptosis, being distinct, share some traits (e.g., chromatin condensation and nuclear deformation).
It was shown here that a permeable caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp-(OMe) fluoromethyl ketone (zVAD.fmk),
prevented the development of the poliovirus-induced apoptosis on abortive infection. The apoptotic pathway could be dissected
by an inhibitor of chymotrypsin-like serine proteases, N-tosyl-L-phenylalanine chloromethyl ketone (TPCK), which prevented the
cleavage of DNA to oligonucleosome-sized pieces and nuclear fragmentation but did not suppress cellular shrinkage, cytoplasmic
blebbing, and partial chromatin condensation. These results demonstrate that caspase activation is involved in the execution
phase of the viral apoptosis and suggest that a nuclear subset of the apoptotic program is under a separate control, involving a
TPCK-sensitive event. Neither zVAD.fmk nor TPCK, at the concentrations affecting the apoptotic response, exerted appreciable
influence on the virus growth or cellular pathological changes on productive infection, indicating that the pathways leading to the
poliovirus-evoked CPE and apoptosis are different. © 1998 Academic Press
INTRODUCTION
Poliovirus infection of susceptible cells is generally
cytocidal. The virus-induced pathological changes,
known as “cytopathic effect” (CPE), take place in the both
cytoplasm and nucleus. The most characteristic cyto-
plasmic alteration consists in the rapid accumulation of
numerous vesicular structures (Bienz et al., 1983; Dales
et al., 1965), driven through an unknown mechanism by
virus-specific nonstructural proteins encoded in the cen-
tral region of the viral genome (Bienz et al., 1990; Cho et
al., 1994; Teterina et al., 1997). The vesicles also contain
other viral proteins, as well as viral RNA species, and
serve as the site for viral genome replication (Bienz et al.,
1980, 1992; Egger et al., 1996). The infected cells round
up, suggesting that the altered plasma membrane loses
its contact with external substratum. By the end of the
viral replication cycle, gross alterations in the permeabil-
ity of cellular membranes take place (Carrasco, 1995).
The nuclei of the infected cells become distorted and
wrinkled at a relatively early phase of the growth cycle;
they are pushed aside to the cellular periphery. Chroma-
tin is condensed in clumps that are attached to the
nuclear membrane (Koch and Koch, 1985). Biochemical
mechanisms underlying this “pyknosis” are unknown.
Poliovirus is also able to induce a different type of the
cell death. Under certain conditions restricting viral re-
production, one can observe the shrinkage of the in-
fected cells accompanied by cytoplasmic blebbing, chro-
matin condensation and detachment from the nuclear
membranes, and degradation of the nuclear DNA into
oligonucleosome-sized species, followed by fragmenta-
tion of the cells into membrane-surrounded pieces, “ap-
optotic bodies” (Tolskaya et al., 1995). These changes,
occurring before gross plasma membrane permeability
changes, are typical of apoptosis, the genetically en-
coded program of cell sacrifice, which plays a key role in
many physiological processes (Jacobson et al., 1997;
Wyllie et al., 1980) and often is turned on in response to
a variety of pathogenic stimuli (Liles, 1997), including
viral infections (Teodoro and Branton, 1997). On produc-
tive infection under the permissive conditions, the devel-
opment of apoptotic reaction appears to be suppressed
by a distinct antiapoptotic function of poliovirus (Tolskaya
et al., 1995).
The apoptotic death is known to involve a cascade of
proteolytic events accomplished mainly by a class of
cysteine proteinases, caspases (Alnemri et al., 1996;
Nicholson and Thornberry, 1997; Salvesen and Dixit,
1997; Villa et al., 1997), and is controlled by a balance
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of numerous proapoptotic and antiapoptotic proteins
(Anderson, 1997; Nagata, 1997; Rao and White, 1997).
Morphological alterations characteristic of apoptosis are
generally believed to result from the proteolysis of struc-
tural components of the cytoplasm, such as actin (Kay-
alar et al., 1995), fodrin (Martin et al., 1995), gelsolin
(Kothakota et al., 1997), and keratins (Caulı´n et al., 1997),
as well as of the nuclei, such as lamins (Orth et al., 1996;
Rao et al., 1996; Takahashi et al., 1996), nuclear matrix-
associated protein NuMA (Gueth-Hallonet et al., 1997),
and scaffold attachment factor A (Go¨hring et al., 1997)
(reviewed by Cohen, 1997; Rosen and Casciola-Rosen,
1997). DNA fragmentation appears to be caused by a
specific nuclease designated DFF-40 (for DNA fragmen-
tation factor; Liu et al., 1997) or CAD (for caspase-acti-
vated deoxyribonuclease; Enari et al., 1998). This enzyme
is normally located in the cytoplasm in the form tightly
complexed with, and inactivated by, an inhibitor (DFF-45
or ICAD). In the course of the implementation of the
apoptotic program, the inhibitor is cleaved, perhaps by
caspase 3, and the active nuclease, due to unmasking of
its nuclear localization signal, translocates from the cy-
toplasm into the nucleus and degrades the chromosomal
DNA (Enari et al., 1998; Liu et al., 1997; Sakahira et al.,
1998). A permeable irreversible inhibitor of different
caspases, benzyloxycarbonyl-Val-Ala-Asp-(OMe) fluoro-
methyl ketone (zVAD.fmk) (Fearnhead et al., 1995; Living-
ston, 1997), prevents the development of apoptosis in
many systems.
Caspases are a major, but not the only, class of pro-
teases thought to be involved in the execution phase of
apoptosis. For example, an inhibitor of chymotrypsin-like
serine proteases, N-tosyl-L-phenylalanine chloromethyl
ketone (TPCK), was reported to induce (Lu and Melgren,
1996; Wu et al., 1996) and prevent (Higuchi et al., 1995; Lu
and Melgren, 1996) the development of apoptosis in
various cellular systems. In some cases, the inhibitor
exerted the opposite effects on the same cells depend-
ing on the concentrations used (Zhu et al., 1997). Some
forms of apoptosis were suppressed by an inhibitor of
trypsin-like proteases, N-tosyl-L-lysine chloromethyl ke-
tone (TLCK) (Fearnhead et al., 1995; Stefanis et al., 1997),
and in some cases, selective sensitivity to either TPCK or
TLCK was reported (Lotem and Sachs, 1996; Rouquet et
al., 1996). There are indications that apoptosis-related
proteolysis of some cytoskeleton proteins, such as actin
(Brown et al., 1997) and NuMA (Gueth-Hallonet et al.,
1997), is accomplished by proteases other than cas-
pases.
To evaluate the possible involvement of caspases and
serine proteases in the cytopathic and apoptotic
changes triggered by poliovirus infection, the effects of
zVAD.fmk, TPCK, and TLCK on these cellular reactions
were studied here.
RESULTS
Morphological manifestations of poliovirus-induced
CPE and apoptosis
HeLa cells dying on productive poliovirus infection
exhibited characteristic cytoplasmic and nuclear alter-
ations. A major cytoplasmic change consisted of the
appearance of numerous membranous vesicles. Under
the electron microscope, nuclei appeared highly dis-
torted and displaced to the cellular periphery. The chro-
matin was condensed and always attached to the nu-
clear membrane, except for sites of nuclear pores (Figs.
1a and 1b). A good idea of the overall nuclear shape in
cells undergoing CPE could be derived from inspection
of preparations stained with a permeable nuclear fluo-
rescent dye, Hoechst-33342 (Fig. 2a). Nuclei were cres-
cent shaped with cup-like indentations. Condensed
chromatin was visible at the border of altered nuclei.
Such a condensation of chromatin was not accompanied
by a detectable fragmentation of DNA (Tolskaya et al.,
1995).
When the expression of the viral genome was severely
suppressed, such as through infection in the presence of
millimolar concentrations of guanidine–HCl, the infected
cells developed a typical apoptotic response. A major
cytoplasmic feature in this case was cellular shrinkage,
cytoplasmic blebbing (Table 1), and the absence of the
infection-specific vesicular structures (Tolskaya et al.,
1995). The apoptotic nuclei exhibited condensation and
margination of chromatin. The condensed chromatin ap-
peared detached, on longer or shorter stretches, from
the nuclear membrane, and irregularly sized bright areas
became scattered through the entire chromatin (Figs. 1c
and 1d). Although the difference between the abundant
fractions of the apoptotic and CPE nuclei was sufficiently
clear, some general similarity in the appearance of chro-
matin under these two conditions also was obvious (Fig.
1). At the final stages, nuclear fragmentation into numer-
ous droplet-like bodies occurred (Fig. 3a). A biochemical
hallmark of the apoptotic cells resulting from the abortive
poliovirus infection was fragmentation (“laddering”) of
nuclear DNA into oligonucleosome-sized pieces (Figs. 4,
lane 3, and 5, lane 4).
A caspase inhibitor prevents the development of
apoptosis but not CPE
The effect of zVAD.fmk on the poliovirus-triggered ap-
optosis and CPE on abortive and productive infections,
respectively, was studied. The inhibitor, at concentra-
tions of 100–200 mM, efficiently suppressed all of the
signs of the apoptotic response to the poliovirus infec-
tion in the presence of guanidine, as judged by inspec-
tion of the Hoechst-stained cells (Fig. 3b and Table 1),
electron microscopy (Fig. 6a), absence of both cytoplas-
mic blebbing (Table 1), and DNA laddering (Fig. 4, lane
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FIG. 1. Electron microscopic features of nuclei of HeLa cells undergoing poliovirus-evoked CPE and apoptosis. (a) Cell with CPE after 5 h of
productive infection. Condensed chromatin (CC), tightly associated with the entire inner nuclear membrane (arrowheads), contained regularly sized
light areas (indicative for nuclear pores) adjacent to the membrane (arrows). (b) Similar cell at a higher magnification, showing enlargement of the
perinuclear space (arrow) and condensed chromatin lining the inner nuclear membrane, except for sites of nuclear pores. (c) Apoptotic cell (after an
8-h infection in the presence of guanidine) with condensed chromatin (CC) containing light areas of varying sizes scattered irregularly throughout the
chromatin. The chromatin is mostly detached from the inner nuclear membrane (arrowheads). The perinuclear space is not or less enlarged than in
permissive infection. (d) Similar cell showing detached condensed chromatin and the not enlarged perinuclear space. (e and f) Uninfected cell
(incubated in the serum-free Eagle’s medium for 8 h) with a small rim of chromatin (C) and a nonenlarged perinuclear space. Bars: 500 nm.
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4). On the other hand, no appreciable effect of this
inhibitor on morphological features of the poliovirus CPE
could be observed on Hoechst-33342 staining (Fig. 2b)
and electron microscopy (Fig. 6b). In the concentrations
used, zVAD.fmk exerted a very small, if any, effect on the
yield of infectious virus on productive infections (no de-
tectable suppression and a decrease in the harvest by
,30% in the presence of 100 and 200 mM of the inhibitor,
respectively).
A serine protease inhibitor interrupts full
implementation of the apoptotic program
TPCK, in the concentration range often used in the
literature (20–100 mg/ml), proved to be toxic for HeLa
cells, as judged by the dramatic (several orders of mag-
nitude) lowering of the virus yield from the productively
infected cells and morphological changes in the unin-
fected cells (not shown). Therefore, the effect of TPCK on
the apoptosis development on abortive poliovirus infec-
tion was studied at lower concentrations of the inhibitor
(e.g., 5 and 10 mg/ml) at which, respectively, no and
,2-fold suppression of the viral progeny yield could be
observed on productive infections. In such concentra-
tions, the drug did not suppress the accumulation of cells
with nuclei containing condensed chromatin under the
abortive infection (Table 1), but the chromatin in the
abundant fraction of these nuclei appeared as a more or
less round unfragmented body (Figs. 3c and 7a), in con-
trast to the predominant fraction of apoptotic nuclei in the
absence of TPCK where chromatin fragmentation into
smaller droplet-like entities was a typical feature (Fig.
3a). At a concentration of 10 mg/ml, TPCK completely
prevented DNA fragmentation (Fig. 5, lane 6), whereas
small amounts of high-molecular-mass DNA could be
FIG. 2. Gross nuclear morphology of HeLa cells undergoing CPE as revealed by Hoechst-33342 staining. Infected HeLa cells (a–c) incubated in
the absence of inhibitors (a), the presence of zVAD.fmk (100 mM) (b), or TPCK (10 mg/ml) (c) for 6 h show classical CPE. Uninfected cells (d–f) incubated
for 12 h in the presence of guanidine–HCl (100 mg/ml) (d), guanidine plus TPCK (e), or guanidine plus zVAD.fmk plus TPCK (f) show normal
appearance.
346 AGOL ET AL.
detected in the samples containing a 5 mg/ml concen-
tration of the inhibitor (Fig. 5, lane 5). On the other hand,
cytoplasmic blebbing was not prevented in the presence
of TPCK (Table 1).
The appearance of cells undergoing CPE on produc-
tive infection was unaffected by the presence of the
same concentrations of TPCK, as judged by both fluo-
rescent microscopy of the Hoechst-stained cells (Fig. 2c)
and electron microscopy (Fig. 7b).
To determine whether the suppressive effect of TPCK
on the development of the poliovirus-triggered apoptosis
was due to interruption of the “normal” apoptotic program
or the inhibitor triggered an entirely different cell death
pathway, a combined effect of TPCK and zVAD.fmk on the
cells undergoing abortive poliovirus infection was stud-
ied. When the two inhibitors were present together, the
development of apoptosis was fully suppressed, judging
by both nuclear (Fig. 3d) and cytoplasmic (Table 1) man-
ifestations. Thus the TPCK target appeared to be down-
stream of the zVAD.fmk-sensitive event. In other words,
TPCK prevented some of the final stages of the canonical
apoptotic response.
An inhibitor of trypsin-like serine proteinases, TLCK, at
the concentrations that did not affect the virus yield on
productive infection (e.g., 50 mg/ml), exerted no appre-
ciable effects on the apoptotic cellular morphology or
DNA fragmentation on the abortive infection (not shown).
DISCUSSION
One of the common cellular responses to many viral
infection consists of turning on a standard set of degra-
dative processes collectively known as apoptosis. Such
self-sacrifice of the host cell is considered a defensive
reaction, which prevents generation and spread of the
viral progeny. On the other hand, several viruses have
evolved one or more tools to suppress this defense
mechanism (reviewed in Gillet and Brun, 1996; Teodoro
and Branton, 1997). Poliovirus exerts strong CPE in many
cell cultures grown in vitro. This effect, while sharing
some features with a typical apoptotic reaction (e.g.,
chromatin condensation and margination), critically dif-
fers from the latter by the absence of such key traits as
degradation of chromosomal DNA to oligonucleosome-
sized fragments, nuclear fragmentation, and cytoplasmic
blebbing (Tolskaya et al., 1995). The typical apoptotic
pattern could, however, develop in poliovirus-infected
cells under conditions restricting productive infection.
Thus the apoptosis-inducing capacity may be masked by
an apoptosis-preventing function encoded in the same
viral genome (Tolskaya et al., 1995).
As a step to obtain insight into these complex virus–
cell relationships, we attempted to define the role of
caspases and serine proteases in these processes. The
results reported here demonstrated that apoptosis de-
veloping on abortive poliovirus infection depended on
the activity of one or more caspases, as evidenced by the
ability of zVAD.fmk to prevent the appearance of any
apoptotic signs. A TPCK-sensitive step turned out also to
be involved in the completion of the apoptotic response,
although apoptosis could begin in the presence of this
inhibitor. Due to its TPCK sensitivity, the poliovirus-in-
duced apoptosis could be placed into the group that
includes some other apoptotic systems in which serine
proteases appear to be involved (Stefanis et al., 1997;
Zhivotovsky et al., 1997). There is evidence that at least in
some such systems, serine proteases act upstream of
the caspase activation (Dubrez et al., 1996; Stefanis et al.,
1997; Suzuki et al., 1997), suggesting that serine pro-
teases may be involved not only in the control of DNA
degradation but also in the activation of the caspase
cascade. By contrast, in our system as well as in some
others (Ghibelli et al., 1995; Zhu et al., 1997), the TPCK-
sensitive step appeared to be downstream of the onset
of this cascade because some apoptotic manifestations,
such as incomplete chromatin condensation and cyto-
plasmic blebbing, were not suppressed by TPCK. It may
be added parenthetically that by assaying different man-
ifestations of apoptosis, it is possible to arrive at the
opposite conclusions with regard to the TPCK effect. If
TABLE 1
Effects of Inhibitors on the Viral Apoptosis
Chromatin
condensation
Cytoplasmic
blebbing
Trypan blue
staining
Gua 0
Virus 1 Gua 35 22 4
Virus 1 Gua 1 zVAD
(100 mM) 2 0.4 4
Gua 1
Virus 1 Gua 30 15 8
Virus 1 Gua 1 zVAD
(200 mM) 1 0.5 7
Gua 1 TPCK (10 mg/ml) 1
Virus 1 Gua 37 20 7
Virus 1 Gua 1 TPCK
(5 mg/ml) 35 23 5
Virus 1 Gua 1 TPCK
(10 mg/ml) 46 36 7
Gua 1 TPCK 1 zVAD 1
Virus 1 Gua 29
Virus 1 Gua 1 zVAD
(100 mM) 1
Virus 1 Gua 1 TPCK
(10 mg/ml) 29
Virus 1 Gua 1 TPCK
1 zVAD 1
Note. Uninfected and poliovirus-infected HeLa cells were incubated
for 12 h in the presence of 100 mg/ml guanidine-HCl (Gua), zVAD.fmk,
and/or TPCK, as indicated. Two former inhibitors were present from the
onset of incubation (infection), whereas the latter was added 3 h later.
The numbers correspond to the percentage of cells exhibiting relevant
features, with $800 nuclei counted for chromatin condensation and
$200 cells for the two other parameters.
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the outcome is judged, as is often the case, by the
absence of DNA laddering, one might conclude that the
inhibitor possessed a strong antiapoptotic activity,
whereas the drug would be considered ineffective in the
same system, if cell viability, phosphatidyl serine exter-
nalization, or cytoplasmic blebbing had been used as a
criterion.
The effect of TPCK on the poliovirus-evoked apoptosis
could likely be explained by postulating that it prevented
activation of the apoptotic DNase. Interestingly, in a sys-
tem in which TPCK at high concentrations induced apo-
ptosis through caspase activation, neither DNA ladder-
ing nor “full” chromatin condensation has been observed
(Zhu et al., 1997). This fact reinforces the conclusion that
TPCK may, under certain settings, specifically inhibit ac-
tivation of the relevant nuclease. However, the actual
TPCK target is unknown. It may be a caspase, which
cleaves the inhibitor (DFF-45/ICAD) of the apoptotic
DNase, because suppression of purified caspase 3 or
caspase 7 by a relatively high concentration of TPCK has
been demonstrated (Fernandes-Alnemri et al., 1995).
However, such an explanation of the TPCK effect on the
poliovirus-induced apoptosis seems not very likely be-
cause under the conditions used by Fernandes-Alnemri
et al. (1995), TLCK was also inhibitory, whereas it was
entirely inactive in our system. Another, more attractive
possibility is that the TPCK target on abortive poliovirus
infections is an unidentified chymotrypsin-like serine
protease able directly or indirectly to inactivate DFF-45/
FIG. 3. Effect of inhibitors on nuclear morphology of apoptotic cells stained with Hoechst-33342. Poliovirus-infected HeLa cells were incubated for
12 h in the presence of guanidine–HCl without other inhibitors (a) or, in addition, with zVAD.fmk (100 mM) (b), TPCK (10 mg/ml) (c), and zVAD.fmk1TPCK
(d). zVAD.fmk and TPCK were added at 0 and 3 h p.i., respectively. The former inhibitor prevented apoptosis completely, whereas the latter inhibited
it partially, with nuclei showing chromatin condensation but no fragmentation.
FIG. 4. DNA fragmentation on poliovirus-induced apoptosis and its
prevention by zVAD.fmk. HeLa cells were infected in the presence of
100 mg/ml guanidine–HCl and incubated for 12 h with or without
zVAD.fmk (100 mM). DNA was extracted and electrophoresed as de-
scribed under Materials and Methods.
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ICAD. The participation of a TPCK-sensitive enzyme
other than a serine protease also cannot rigorously be
ruled out.
The absence of strong chromatin condensation and
marked nuclear fragmentation in apoptotic cells in the
presence of TPCK might suggest that these features are
causally related to the DNA degradation (compare with
Ghibelli et al., 1995). However, chromatin condensation
and nuclear fragmentation may precede DNA degrada-
tion, at least in some forms of apoptosis (Allera et al.,
1997; Collins et al., 1997). In this respect, it is relevant to
note that apoptotic proteolysis of the nuclear matrix-
associated protein NuMA is accomplished by a TPCK-
sensitive protease (Gueth-Hallonet et al., 1997). The pos-
sibility of cleavage of a lamin by serine protease also has
been reported (Zhivotovsky et al., 1997). Thus TPCK
might have more than one target or the putative TPCK-
sensitive protease might be involved in the cleavage of
several substrates.
Notwithstanding the uncertainty regarding the nature
of the TPCK target, the very fact that the inhibitor
prevented generation of oligonucleosome-sized DNA
pieces, full chromatin condensation, and nuclear frag-
mentation demonstrated that this subset of nuclear ap-
optotic changes is under an autonomous control. Other
conditions are known under which the above signs of
apoptosis can be selectively suppressed without appre-
ciable effect on its other manifestations, like cytoplasmic
blebbing, externalization of phosphatidyl serine, or par-
tial chromatin condensation. For example, such selective
FIG. 5. Effect of TPCK on the DNA fragmentation during the poliovi-
rus-induced apoptosis. The experiment was carried out as described in
the legend to Fig. 4, except for the nature of the protease inhibitor,
which was added at 3 h p.i.
FIG. 6. Effects of zVAD.fmk on poliovirus-induced apoptosis (a) and CPE (b) as revealed by electron microscopy. (a) HeLa cells were infected in
the presence of 100 mg/ml guanidine–HCl and incubated for 8 h with zVAD.fmk (50 mM). The nucleus has normal appearance as in uninfected cells
(compare Figs. 1e and 1f) and exhibits no signs of apoptosis (compare Figs. 1c and 1d). (b) HeLa cells were infected in the presence of zVAD.fmk
(50 mM) for 5 h. The inhibitor exerted no appreciable effect on the morphological features of CPE on productive infection (compare Figs. 1a and ab).
Bars: 1 mm.
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effects have been reported for specific peptide inhibitors
of the caspase 3-like proteases (McCarthy, et al., 1997;
Toyoshima et al., 1997; Xiang et al., 1996). Likewise,
infection with herpes simplex virus type 1 prevented
DNA fragmentation but not phosphatidyl serine external-
ization evoked by different apoptotic stimuli (Jerome et
al., 1998). Thus the subset of apoptotic reactions that
leads to DNA degradation may not necessarily be an
integral part of the cell death program, nor is this part an
obligatory one because the cells will eventually die, even
when DNA fragmentation is suppressed (McCarthy, et
al., 1997; Toyoshima et al., 1997; Xiang et al., 1996) and
instances of apoptosis without DNA laddering have been
described (Bernard et al., 1997; Fournel et al., 1995;
Odaka and Ucker, 1996; Simm et al., 1997).
The level of independence of the control of DNA deg-
radation and nuclear fragmentation within the general
apoptotic response may vary in different systems, de-
pending both on the character of apoptotic stimuli and on
the cell type. In this regard, it may be noted that on the
actinomycin D-induced apoptosis in uninfected HeLa
cells (Tolskaya et al., 1995, 1996), TPCK also prevented
DNA degradation and nuclear fragmentation (but not
partial chromatin condensation and cytoplasmic bleb-
bing) (unpublished observations).
The data reported here demonstrated a similarity be-
tween the execution stages of the poliovirus-induced
apoptosis and apoptosis triggered by another group of
positive-strand RNA viruses, alphaviruses, with respect
to the caspase involvement (Griffin and Hardwick, 1997;
Nava et al., 1998). The mechanism or mechanisms and
control of the caspase activation on the viral infection
remain open questions.
As shown here, the pathway leading to chromatin
condensation and nuclear morphological changes dur-
ing the productive infection was distinct from that oper-
ating during the apoptotic response. There is some su-
perficial similarity between the CPE and the viral apo-
ptosis (in particular, its incomplete form observed in the
presence TPCK). The former, however, differs from the
latter with respect to nuclear morphology, plasma mem-
brane change, and, particularly, sensitivity to zVAD.fmk.
We are aware of no specific biochemical reaction that
could be responsible for the nuclear component of the
poliovirus CPE. The virus-induced shut-off of macromo-
lecular synthesis cannot be the immediate cause of
nuclear alterations inasmuch as inhibition of cellular
transcription and translation by actinomycin D plus cy-
cloheximide in the presence of zVAD.fmk (to prevent
apoptosis) was not accompanied by any appreciable
chromatin condensation and nuclear deformation during
the time intervals comparable to those needed for the
FIG. 7. Effects of TPCK on poliovirus-induced apoptosis (a) and CPE (b) as revealed by electron microscopy. (a) HeLa cells were infected for 12 h
in the presence of 100 mg/ml guanidine–HCl, and TPCK (10 mg/ml) was added at 3 h p.i. TPCK prevented nuclear and extensive chromatin
fragmentation but did not prevent chromatin condensation. (b) TPCK (10 mg/ml) was added to the cells productively infected for 5 h. TPCK did not
change the appearance of CPE. Bars: 1 mm.
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development of CPE (unpublished observations). The
appearance of nuclei as indented crescents (Fig. 2) and
the adherence of chromatin to nuclear membranes (Figs.
1a and 1b) could be taken as circumstantial evidence
that nuclear changes during the poliovirus CPE are, at
least to some extent, a result of external pressure from
the expanding cytoplasmic vesicular network. This no-
tion obviously requires more direct testing.
MATERIALS AND METHODS
Virus, cells, and protease inhibitors
A subline of HeLa-S3 cells designated HeLa-B (Tol-
skaya et al., 1995), cultivated in basal Eagle’s medium
supplemented with 10% bovine serum, was used in sin-
gle cycle of viral reproduction experiments. Aliquots (2.5
ml) of versenized cells (3–4 3 105 cells/ml) were plated
onto plastic 35-mm petri dishes (Corning-Costar). One-
day-old cultures grown under 5% CO2 at 37°C were used
for the experiments. For the infection, the growth medium
was discarded, and 2 ml of bicarbonate-free Eagle’s
medium containing 3 3 109 PFU of a derivative of polio-
virus type 1 Mahoney strain, Mgs (Tolskaya et al., 1983),
was added. After a 30-min incubation at ambient tem-
perature, the cells were washed off with Earle’s solution,
and 2 ml of serum-free Eagle’s medium containing, if
appropriate, relevant inhibitors was added. After incuba-
tion at 37°C for the time intervals indicated, the viral
harvest was plaque titrated on RD cells.
zVAD.fmk was purchased from Enzyme Systems Prod-
ucts (Dublin, CA), and TPCK and TLCK were from Serva.
Microscopy
The fluorescent permeable nuclear dye Hoechst-
-33342 (Sigma) was added to a final concentration of 5
mg/ml to the HeLa cell monolayers 30 min before the end
of the relevant incubation period. The cells were fixed
with Safe Fix (Curtin Matheson Scientific, Houston, TX)
for 30 min and washed twice with H2O. A drop of a
glycerol–1 M Tris–HCl mixture, pH 7.5 (9:1), was added,
and the cells were covered with a coverslip and viewed
with an epifluorescent microscope (Leica DMLS)
equipped with filter A. For the quantification of nuclear
alterations, several fields were photographed at a mag-
nification of 3200, the films were projected onto a
screen, and $800 nuclei were counted in each sample.
The proportions of dead cells and cells exhibiting
cytoplasmic blebbing were determined by light micros-
copy using versenized cell preparations stained with
0.01% methylene blue.
For electron microscopy, the detached cells were fixed
with 2.5% glutaraldehyde and subsequently with 1%
OsO4 and then embedded into EPON-812. Ultrathin sec-
tions were examined with a Philips CM 100 or JEM-
1200-II microscopes.
DNA analysis
DNA fragmentation was assayed as described previ-
ously (Tolskaya et al., 1995). Versenized cells (2–3 3 106),
suspended in a buffer containing 20 mM EDTA and 10
mM Tris–HCl, pH 7.4, were treated with 0.5% Triton X-100
for 20 min at 0°C. After pelleting intact chromatin in an
Eppendorf centrifuge (12,000 rpm, 15 min, 4°C), sodium
dodecyl sulfate was added to the supernatant to a final
concentration of 1%, and phenol deproteinization was
performed. Ethanol-precipitated nucleic acids were dis-
solved in 10 ml of H2O and treated with RNase A (10
mg/ml, 37°C, 30 min). Glycerol was added to a final
concentration of 8%, and samples were subjected to
electrophoresis on 1.5% agarose gels.
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